These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 301779)

  • 1. Aspects of the reversal of methotrexate toxicity in rodents.
    Kisliuk RL; Tattersall MH; Gaumont Y; Pastore EJ; Brown B
    Cancer Treat Rep; 1977 Jul; 61(4):647-50. PubMed ID: 301779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory control of tetrahydrofolate coenzymes in folate auxotrophs.
    Albrecht AM
    Cancer Treat Rep; 1977 Jul; 61(4):533-8. PubMed ID: 301776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of methotrexate toxicity in mice by a calcium salt of citrovorum factor and related compounds.
    Temple C; Rose JD; Laster WR; Montgomery JA
    Cancer Treat Rep; 1981; 65(11-12):1117-9. PubMed ID: 6975166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-5-formyltetrahydrofolate and l-5-methyltetrahydrofolate rescue in L1210 leukemia treated with high methotrexate doses.
    Simile MM; DeMiglio MR; Nufris A; Pascale RM; Muroni MR; Feo F
    Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):251-4. PubMed ID: 8210704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-induced developmental toxicity in rabbits is ameliorated by 1-(p-tosyl)-3,4,4-trimethylimidazolidine, a functional analog for tetrahydrofolate-mediated one-carbon transfer.
    DeSesso JM; Goeringer GC
    Teratology; 1992 Mar; 45(3):271-83. PubMed ID: 1631781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of malnutrition on methotrexate toxicity and tissue levels of dihydrofolate reductase in the rat.
    Grossie VB; Ho DH; Loo TL
    Cancer Treat Rep; 1982 Jan; 66(1):85-9. PubMed ID: 7053272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase.
    Gori JL; Podetz-Pedersen K; Swanson D; Karlen AD; Gunther R; Somia NV; McIvor RS
    J Pharmacol Exp Ther; 2007 Sep; 322(3):989-97. PubMed ID: 17586722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells.
    Boarman DM; Baram J; Allegra CJ
    Biochem Pharmacol; 1990 Dec; 40(12):2651-60. PubMed ID: 2260989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple radiometric assay for methotrexate and other folate antagonists.
    Hayman RJ; Fong H; Van der Weyden MB
    J Lab Clin Med; 1979 Mar; 93(3):480-4. PubMed ID: 311801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid.
    Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB
    Mutat Res; 2009 Feb; 673(1):43-52. PubMed ID: 19110071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrofolate-mediated reversal of methotrexate toxicity to hepatoma cells in vitro.
    Kruger-McDermott C; Balinska M; Galivan J
    Cancer Lett; 1986 Jan; 30(1):79-84. PubMed ID: 3484673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase.
    Iven H; Bartels H
    Cancer Treat Rep; 1985; 69(7-8):825-32. PubMed ID: 4016793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID; Matherly LH
    NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct ligand-binding radioassay for the measurement of methotrexate in tissues and biological fluids.
    Arons E; Rothenberg SP; Costa MD; Fischer C; Iqbal MP
    Cancer Res; 1975 Aug; 35(8):2033-8. PubMed ID: 807320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of methotrexate in rats preexposed to nitrous oxide.
    Ermens AA; Schoester M; Spijkers LJ; Lindemans J; Abels J
    Cancer Res; 1989 Nov; 49(22):6337-41. PubMed ID: 2804978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.